NCT05947955: Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) |
|
|
| Recruiting | 2 | 600 | Europe, US | Rhu-pGSN, recombinant human gelsolin, normal saline, 0.9% sterile saline | BioAegis Therapeutics Inc., Biomedical Advanced Research and Development Authority | Acute Respiratory Distress Syndrome, Infections | 10/26 | 03/27 | | |